• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌中差异表达的微小RNA的综合计算分析及其对转录组特征的影响。

Comprehensive computational analysis of differentially expressed miRNAs and their influence on transcriptomic signatures in prostate cancer.

作者信息

Aldakheel Fahad M, Alnajran Hadeel, Mateen Ayesha, Alduraywish Shatha A, Alqahtani Mohammed S, Syed Rabbani

机构信息

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, P.O. Box 10219, Riyadh, 11433, Saudi Arabia.

Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

出版信息

Sci Rep. 2025 Jan 29;15(1):3646. doi: 10.1038/s41598-025-85502-4.

DOI:10.1038/s41598-025-85502-4
PMID:39881138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11779938/
Abstract

Prostate cancer presents a major health issue, with its progression influenced by intricate molecular factors. Notably, the interplay between miRNAs and changes in transcriptomic patterns is not fully understood. Our study seeks to bridge this knowledge gap, employing computational techniques to explore how miRNAs and transcriptomic alterations jointly regulate the development of prostate cancer. The study involved retrieving miRNA expression data from the GEO database specific to prostate cancer. Identification of DEMs was conducted using the 'limma' package in R. Integration of these DEMs with mRNA interactions was done using the MiRTarBase database. Finally, a network depicting miRNA-mRNA interactions was constructed using Cytoscape software to analyze the regulatory network of prostate cancer. The study pinpointed seven pivotal differentially expressed microRNAs (DEmiRNAs) in prostate cancer: hsa-miR-185-5p, hsa-miR-153-3p, hsa-miR-198, hsa-miR-182-5p, hsa-miR-223-3p, hsa-miR-372-3p, and hsa-miR-188-5p. These miRNAs influence key genes, including FOXO3, NFAT3, PTEN, RHOA, VEGFA, SMAD7, and CDK2, playing significant roles in both tumor suppression and oncogenesis. The analysis revealed a complex network of miRNA-mRNA interactions, comprising 1849 nodes and 3604 edges. Functional Enrichment Analysis through ClueGO highlighted 74 GO terms associated with these mRNA targets. This analysis uncovered their substantial impact on critical biological processes and molecular functions, such as cyclin-dependent protein kinase activity, mitotic DNA damage checkpoint signalling, stress-activated MAPK cascade, regulation of extrinsic apoptotic signalling pathway, and positive regulation of cell adhesion. Our analysis of miRNAs and DEGs genes revealed an intriguing mix of established and potentially novel regulators in prostate cancer development. These findings both reinforce our current understanding of prostate cancer's molecular landscape and point to unexplored pathways that could lead to novel therapeutic strategies. By mapping these regulatory relationships, our work contributes to the growing knowledge base needed for developing more targeted and effective treatments.

摘要

前列腺癌是一个重大的健康问题,其进展受复杂分子因素的影响。值得注意的是,miRNA与转录组模式变化之间的相互作用尚未完全明确。我们的研究旨在填补这一知识空白,运用计算技术探索miRNA和转录组改变如何共同调节前列腺癌的发展。该研究涉及从特定于前列腺癌的GEO数据库中检索miRNA表达数据。使用R语言中的“limma”软件包进行差异表达miRNA(DEM)的鉴定。利用MiRTarBase数据库将这些DEM与mRNA相互作用进行整合。最后,使用Cytoscape软件构建描绘miRNA-mRNA相互作用的网络,以分析前列腺癌的调控网络。该研究确定了前列腺癌中七个关键的差异表达微小RNA(DEmiRNA):hsa-miR-185-5p、hsa-miR-153-3p、hsa-miR-198、hsa-miR-182-5p、hsa-miR-223-3p、hsa-miR-372-3p和hsa-miR-188-5p。这些miRNA影响关键基因,包括FOXO3、NFAT3、PTEN、RHOA、VEGFA,、SMAD7和CDK2,它们在肿瘤抑制和肿瘤发生中都发挥着重要作用。分析揭示了一个复杂的miRNA-mRNA相互作用网络,包含1849个节点和3604条边。通过ClueGO进行的功能富集分析突出了与这些mRNA靶标相关的74个基因本体(GO)术语。该分析揭示了它们对关键生物学过程和分子功能的重大影响,如细胞周期蛋白依赖性蛋白激酶活性、有丝分裂DNA损伤检查点信号传导、应激激活的丝裂原活化蛋白激酶级联反应、外在凋亡信号通路的调节以及细胞黏附的正调控。我们对miRNA和差异表达基因(DEG)的分析揭示了前列腺癌发展中既有已确定的调节因子,也有潜在的新调节因子的有趣组合。这些发现既强化了我们目前对前列腺癌分子格局的理解,也指出了可能通向新治疗策略的未探索途径。通过绘制这些调控关系,我们的工作为开发更具针对性和有效性的治疗方法所需的不断增长的知识库做出了贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/534f/11779938/f8a8fe6109a9/41598_2025_85502_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/534f/11779938/fd00fb0e05df/41598_2025_85502_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/534f/11779938/f0889ac7378d/41598_2025_85502_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/534f/11779938/f8a8fe6109a9/41598_2025_85502_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/534f/11779938/fd00fb0e05df/41598_2025_85502_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/534f/11779938/f0889ac7378d/41598_2025_85502_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/534f/11779938/f8a8fe6109a9/41598_2025_85502_Fig3_HTML.jpg

相似文献

1
Comprehensive computational analysis of differentially expressed miRNAs and their influence on transcriptomic signatures in prostate cancer.前列腺癌中差异表达的微小RNA的综合计算分析及其对转录组特征的影响。
Sci Rep. 2025 Jan 29;15(1):3646. doi: 10.1038/s41598-025-85502-4.
2
Gene Coexpression and miRNA Regulation: A Path to Early Intervention in Colorectal Cancer.基因共表达和 miRNA 调控:结直肠癌早期干预的途径。
Hum Gene Ther. 2024 Oct;35(19-20):855-867. doi: 10.1089/hum.2023.207. Epub 2024 Jul 4.
3
Exploring the Shared miRNA-mRNA Signature Network Between Helicobacter pylori Infection and Gastric Cancer: A Comparative Study.探索幽门螺杆菌感染与胃癌之间共享的miRNA-mRNA特征网络:一项比较研究
Curr Microbiol. 2025 Jul 7;82(8):366. doi: 10.1007/s00284-025-04336-5.
4
Identification of miRNA signature in cancer-associated fibroblast to predict recurrent prostate cancer.鉴定肿瘤相关成纤维细胞中的 miRNA 特征,以预测前列腺癌的复发。
Comput Biol Med. 2024 Sep;180:108989. doi: 10.1016/j.compbiomed.2024.108989. Epub 2024 Aug 13.
5
Deciphering Shared Gene Signatures and Immune Infiltration Characteristics Between Gestational Diabetes Mellitus and Preeclampsia by Integrated Bioinformatics Analysis and Machine Learning.通过综合生物信息学分析和机器学习破译妊娠期糖尿病和子痫前期之间共享的基因特征及免疫浸润特征
Reprod Sci. 2025 May 15. doi: 10.1007/s43032-025-01847-1.
6
MicroRNAs in oral fluids (saliva and gingival crevicular fluid) as biomarkers in orthodontics: systematic review and integrated bioinformatic analysis.口腔液(唾液和龈沟液)中的 microRNAs 作为正畸学中的生物标志物:系统评价和综合生物信息学分析。
Prog Orthod. 2021 Oct 11;22(1):31. doi: 10.1186/s40510-021-00377-1.
7
Transcriptomic profiling and bioinformatic insights into myocardial injury following aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血后心肌损伤的转录组分析及生物信息学见解
Front Neurol. 2025 Jun 24;16:1492398. doi: 10.3389/fneur.2025.1492398. eCollection 2025.
8
A comprehensive investigation of identifying miRNA biomarkers and their potential role in age-related cataract by meta-analysis and bioinformatics analysis.通过荟萃分析和生物信息学分析全面研究鉴定与年龄相关性白内障相关的miRNA生物标志物及其潜在作用。
Graefes Arch Clin Exp Ophthalmol. 2025 Jan 6. doi: 10.1007/s00417-024-06723-3.
9
Exploring a circulating circRNA and miRNA biomarker panel for early detection of ovarian cancer through multiple omics analysis.通过多组学分析探索用于卵巢癌早期检测的循环环状RNA和微小RNA生物标志物组合。
Sci Rep. 2025 Jul 16;15(1):25809. doi: 10.1038/s41598-025-11641-3.
10
Identification and Characterization of a ceRNA Regulatory Network Involving LINC00482 and PRRC2B in Peripheral Blood Mononuclear Cells: Implications for COPD Pathogenesis and Diagnosis.鉴定和描述涉及 LINC00482 和 PRRC2B 的 ceRNA 调控网络在外周血单个核细胞中的作用:对 COPD 发病机制和诊断的影响。
Int J Chron Obstruct Pulmon Dis. 2024 Feb 8;19:419-430. doi: 10.2147/COPD.S437046. eCollection 2024.

引用本文的文献

1
Identification and verification of oxidative stress-related genes in the diagnosis of osteoporosis.氧化应激相关基因在骨质疏松症诊断中的鉴定与验证
Sci Rep. 2025 Jul 2;15(1):23222. doi: 10.1038/s41598-025-06118-2.
2
Computational Identification and Validation of Metabolic Cell Death-Related Prognostic Biomarkers for Personalized Treatment Strategies in Prostate Cancer.用于前列腺癌个性化治疗策略的代谢性细胞死亡相关预后生物标志物的计算识别与验证
Cell Biochem Biophys. 2025 Apr 11. doi: 10.1007/s12013-025-01746-x.

本文引用的文献

1
miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer.miRNAs:癌症的潜在生物标志物和治疗靶点。
Genes (Basel). 2023 Jun 29;14(7):1375. doi: 10.3390/genes14071375.
2
NFAT signaling dysregulation in cancer: Emerging roles in cancer stem cells.NFAT 信号转导在癌症中的失调:在癌症干细胞中的新作用。
Biomed Pharmacother. 2023 Sep;165:115167. doi: 10.1016/j.biopha.2023.115167. Epub 2023 Jul 14.
3
MicroRNA-372 acts as a double-edged sword in human cancers.微小RNA-372在人类癌症中扮演着双刃剑的角色。
Heliyon. 2023 May 9;9(5):e15991. doi: 10.1016/j.heliyon.2023.e15991. eCollection 2023 May.
4
Anti-angiogenic effect of nano-formulated water soluble kaempferol and combretastatin in an in vivo chick chorioallantoic membrane model and HUVEC cells.纳米水溶胶化山柰酚和康普瑞汀在体内鸡胚尿囊膜模型和 HUVEC 细胞中的抗血管生成作用。
Biomed Pharmacother. 2023 Jul;163:114820. doi: 10.1016/j.biopha.2023.114820. Epub 2023 May 2.
5
Malignant function of nuclear factor-kappaB axis in prostate cancer: Molecular interactions and regulation by non-coding RNAs.核因子-κB 轴在前列腺癌中的恶性功能:分子相互作用及非编码 RNA 的调控。
Pharmacol Res. 2023 Aug;194:106775. doi: 10.1016/j.phrs.2023.106775. Epub 2023 Apr 17.
6
Prostate cancer metastasis and health disparities: a systematic review.前列腺癌转移与健康差异:系统评价。
Prostate Cancer Prostatic Dis. 2024 Jun;27(2):183-191. doi: 10.1038/s41391-023-00667-1. Epub 2023 Apr 12.
7
Computational approaches for discovering significant microRNAs, microRNA-mRNA regulatory pathways, and therapeutic protein targets in endometrial cancer.用于发现子宫内膜癌中重要微小RNA、微小RNA-信使核糖核酸调控途径及治疗性蛋白质靶点的计算方法。
Front Genet. 2023 Jan 10;13:1105173. doi: 10.3389/fgene.2022.1105173. eCollection 2022.
8
A comparative mRNA- and miRNA transcriptomics reveals novel molecular signatures associated with metastatic prostate cancers.一项比较性的mRNA和miRNA转录组学研究揭示了与转移性前列腺癌相关的新分子特征。
Front Genet. 2022 Nov 16;13:1066118. doi: 10.3389/fgene.2022.1066118. eCollection 2022.
9
On the role of mechanical signals on sprouting angiogenesis through computer modeling approaches.通过计算机建模方法探讨机械信号在血管生成中的作用。
Biomech Model Mechanobiol. 2022 Dec;21(6):1623-1640. doi: 10.1007/s10237-022-01648-4. Epub 2022 Nov 17.
10
The potential of miR-153 as aggressive prostate cancer biomarker.miR-153作为侵袭性前列腺癌生物标志物的潜力。
Noncoding RNA Res. 2022 Oct 13;8(1):53-59. doi: 10.1016/j.ncrna.2022.10.002. eCollection 2023 Mar.